17.48
前日終値:
$17.96
開ける:
$17.77
24時間の取引高:
13.91M
Relative Volume:
1.16
時価総額:
$18.49B
収益:
$16.54B
当期純損益:
$-1.64B
株価収益率:
-12.06
EPS:
-1.45
ネットキャッシュフロー:
$749.00M
1週間 パフォーマンス:
+8.44%
1か月 パフォーマンス:
+29.87%
6か月 パフォーマンス:
+3.19%
1年 パフォーマンス:
+3.55%
Teva Pharmaceutical Industries Ltd Adr Stock (TEVA) Company Profile
名前
Teva Pharmaceutical Industries Ltd Adr
セクター
電話
972 (3) 914-8213
住所
TEVA PHARMACEUTICAL INDUSTRIES LIMITED, TEL AVIV
TEVA を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.48 | 18.49B | 16.54B | -1.64B | 749.00M | -1.45 |
![]()
ZTS
Zoetis Inc
|
160.41 | 66.72B | 9.29B | 2.52B | 2.28B | 5.57 |
![]()
HLN
Haleon Plc Adr
|
10.45 | 48.08B | 14.35B | 1.85B | 0 | 0.4023 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
13.72 | 47.74B | 30.08B | 710.16M | 4.45B | 0.2182 |
![]()
UTHR
United Therapeutics Corp
|
308.07 | 13.31B | 2.76B | 1.11B | 898.10M | 22.77 |
Teva Pharmaceutical Industries Ltd Adr Stock (TEVA) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-07-10 | アップグレード | Argus | Hold → Buy |
2024-03-08 | アップグレード | JP Morgan | Underweight → Neutral |
2024-02-12 | アップグレード | Piper Sandler | Neutral → Overweight |
2024-01-23 | アップグレード | Jefferies | Hold → Buy |
2024-01-03 | アップグレード | Piper Sandler | Underweight → Neutral |
2023-12-18 | 開始されました | HSBC Securities | Buy |
2023-11-27 | アップグレード | UBS | Neutral → Buy |
2023-07-06 | アップグレード | UBS | Sell → Neutral |
2023-05-25 | 開始されました | Morgan Stanley | Equal-Weight |
2023-05-18 | アップグレード | Evercore ISI | In-line → Outperform |
2023-01-19 | ダウングレード | Jefferies | Buy → Hold |
2022-11-14 | ダウングレード | JP Morgan | Neutral → Underweight |
2022-11-04 | ダウングレード | UBS | Neutral → Sell |
2022-10-21 | 再開されました | Jefferies | Buy |
2022-08-05 | アップグレード | BofA Securities | Neutral → Buy |
2022-06-14 | 再開されました | UBS | Neutral |
2022-05-17 | アップグレード | BofA Securities | Underperform → Neutral |
2022-05-04 | ダウングレード | Piper Sandler | Neutral → Underweight |
2022-04-05 | アップグレード | Barclays | Equal Weight → Overweight |
2022-03-25 | アップグレード | Bernstein | Mkt Perform → Outperform |
2022-01-27 | ダウングレード | Argus | Buy → Hold |
2021-10-28 | ダウングレード | Raymond James | Outperform → Mkt Perform |
2021-05-04 | ダウングレード | UBS | Buy → Neutral |
2021-04-07 | 再開されました | RBC Capital Mkts | Sector Perform |
2020-11-25 | 開始されました | Oppenheimer | Perform |
2020-08-06 | アップグレード | Barclays | Underweight → Equal Weight |
2020-07-27 | 再開されました | Goldman | Neutral |
2020-06-01 | アップグレード | SunTrust | Hold → Buy |
2020-04-24 | 再開されました | Citigroup | Neutral |
2020-04-06 | アップグレード | UBS | Neutral → Buy |
2020-02-24 | ダウングレード | Edward Jones | Hold → Sell |
2019-11-12 | アップグレード | JP Morgan | Underweight → Neutral |
2019-10-17 | アップグレード | Gabelli & Co | Hold → Buy |
2019-08-07 | ダウングレード | Evercore ISI | Outperform → In-line |
2019-07-19 | 開始されました | Wolfe Research | Peer Perform |
2019-07-15 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
2019-07-10 | 再開されました | Credit Suisse | Neutral |
2019-07-05 | アップグレード | Argus | Hold → Buy |
2019-06-11 | 開始されました | Barclays | Underweight |
2019-06-03 | アップグレード | Oppenheimer | Perform → Outperform |
2019-05-30 | ダウングレード | BofA/Merrill | Buy → Underperform |
2019-05-28 | ダウングレード | UBS | Buy → Neutral |
2019-03-20 | 開始されました | SunTrust | Hold |
2019-03-07 | 再開されました | UBS | Buy |
すべてを表示
Teva Pharmaceutical Industries Ltd Adr (TEVA) 最新ニュース
Why Teva Pharmaceuticals Stock Blasted 6% Higher Today - The Motley Fool
Teva Earnings: Innovation Propels Sales and Generics Show Stability in Solid Start to the Year - Morningstar
Teva and Alvotech stocks jump on FDA approval of SELARSDI - Investing.com
Teva and Alvotech stocks jump on FDA approval of SELARSDI By Investing.com - Investing.com Canada
There Are Mixed Signals on the Chart for Teva- Pharmaceutical Industries Ltd. ADR (TEVA) - uspostnews.com
Digi Power X Inc (DGXX)’s highs and lows: A closer look at its stock price fluctuations - uspostnews.com
Market Analysts see Norwegian Cruise Line Holdings Ltd [NCLH] gaining to $21. Time to buy? - dbtnews.com
PG&E Corp [PCG] Revenue clocked in at $24.54 billion, down -14.37% YTD: What’s Next? - dbtnews.com
Greenwave Technology Solutions Inc [GWAV] Is Currently 12.13 above its 200 Period Moving Avg: What Does This Mean? – The DBT News - dbtnews.com
Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Performance and Fundamentals Dashboard tells a completely different story – Sete News - Sete News
Raymond James slashes price target on Adma Biologics Inc [ADMA] – find out why. - dbtnews.com
Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Stock: A Year of Highs and Lows - investchronicle.com
Company’s Banking Stock: Dissecting a 37.52% Quarterly Revenue Decline Amid Growth - investchronicle.com
NEOV’s Market Whiplash: -48.46% YTD Decline, 15.24% Rise in 30 Days - investchronicle.com
Adagio Medical Holdings Inc (ADGM) Stock: Uncovering a 52-Week Range and Trading Volume - investchronicle.com
A company insider recently sold 70,961 shares of Teva- Pharmaceutical Industries Ltd. ADR [TEVA]. Should You Sale? - knoxdaily.com
Introducing Our Rant Against Teva- Pharmaceutical Industries Ltd. ADR - uspostnews.com
OS overperforms with a 2.12 increase in share price - uspostnews.com
For Kopin Corp [KOPN], Analyst sees a rise to $2. What next? - dbtnews.com
Market Analysts see Geron Corp [GERN] falling to $2. Time to buy? - dbtnews.com
Teva- Pharmaceutical Industries Ltd. ADR [TEVA] Is Currently 5.18 below its 200 Period Moving Avg: What Does This Mean? – The DBT News - dbtnews.com
The growth track for Teva- Pharmaceutical Industries Ltd. ADR (TEVA) has changed recently - Sete News
Rezolute Inc: Weathering Stock Market Storms with 190.08M Market Cap - investchronicle.com
Ready to Jump After Recent Trade: NIO Inc ADR (NIO) - Sete News
Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Stock: Exploring a Year of Highs, Lows, and Trading Volume - investchronicle.com
ORCL’s Stock Journey: What Investors Need to Know About Oracle Corp’s Performance - investchronicle.com
TGB Stock Update: Taseko Mines Ltd’s Banking’s Market Struggles and Potential Opportunities - investchronicle.com
Lexicon Pharmaceuticals Inc (LXRX) Stock: A Year of Market Fluctuations - investchronicle.com
HESM’s latest rating updates from top analysts. - knoxdaily.com
Analysts review Teva- Pharmaceutical Industries Ltd. ADR’s rating - knoxdaily.com
Zacks Industry Outlook Dr. Reddy's, Sandoz And Teva Pharmaceuticals - Barchart.com
Is Vera Therapeutics Inc (VERA) a threat to investors? - uspostnews.com
What technical indicators reveal about MYGN stock - uspostnews.com
VF Corp (VFC) is a good investment, but the stock may be overvalued - uspostnews.com
Investing in Calumet Inc (CLMT) might be an excellent idea, but the stock is currently overvalued/undervalued - uspostnews.com
Wabash National Corp (WNC) stock on the rise: An overview - uspostnews.com
The Gryphon Digital Mining Inc (GRYP) had a good session last reading, didn’t it? - uspostnews.com
Generics Industry: India Celebrates Pharmaceutical Tariffs Exemption but Uncertainty Remains High - Morningstar
What will the future hold for CarGurus Inc (NASDAQ:CARG) stock? - US Post News
TEVA’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - investchronicle.com
Teva Pharmaceutical Stock Scores RS Rating Upgrade - MSN
IBD Rating Upgrades: Teva Pharmaceutical ADR Flashes Improved Relative Price Strength - Investor's Business Daily
Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace
How does TEVA’s price to cash per share ratio compare in the market? - US Post News
Teva Pharmaceutical Industries Limited Sponsored ADR to Host Earnings Call - ACCESS Newswire
Validea Detailed Fundamental AnalysisTEVA - Nasdaq
Why weight-loss drugs are the top target of Medicare price negotiations - Equities News
Investor Network: Teva Pharmaceutical Industries Limited Sponsored ADR to Host Earnings Call - ACCESS Newswire
Is the SM Energy Co (NYSE:SM) stock an investment opportunity? - US Post News
Teva Pharmaceutical Stock: Strategic Global Access Initiatives Advance - sharewise
Are Clear Secure Inc’shares a good deal? - US Post News
Teva Pharmaceutical Industries Ltd Adr (TEVA) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):